Chart Events
Performance Outlook
| Previous Close | 0.2201 |
| Open | 0.1941 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1941 - 0.2258 |
| 52 Week Range | 0.1940 - 0.2570 |
| Volume | 151,142 |
| Avg. Volume | 158,820 |
| Market Cap | 17.466M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol
Toronto, Ontario--(Newsfile Corp. - January 14, 2021) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has completed the first step in identifying the medicinal ...
- PR Newswire
KCSA Strategic Communications to Host Inaugural KCSA Psychedelics Investor Conference on January 26-27, 2021
KCSA Strategic Communications, an integrated strategic communications firm specializing in public relations, investor relations and social media, today announced that it will host its inaugural virtual Psychedelics Investor Conference on Tuesday, January 26, 2021 and Wednesday, January 27, 2021 from 9:00am – 12:30pm ET.
- Newsfile
Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol
Toronto, Ontario--(Newsfile Corp. - January 6, 2021) - Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has commenced a study to determine the therapeutic values of muscimol for antioxidant and anti-inflammatory purposes via a nerve derived immunity and neuroprotective modulation models.The ...
